Related Experiment Videos
Timely incidence of retinopathy of prematurity and its consequences for the screening strategy
Insights
Optimal retinopathy of prematurity (ROP) screening requires multiple assessments. Screening between weeks 7-9 offers the best single detection, but multiple screenings improve incidence monitoring and treatment timing.
Area of Science:
- Ophthalmology
- Neonatology
- Public Health
Background:
- Limited data exist for optimal retinopathy of prematurity (ROP) screening strategies.
- Screening must balance incidence monitoring with timely therapeutic intervention.
Purpose of the Study:
- To deduce an optimal screening strategy for retinopathy of prematurity (ROP).
- To evaluate the effectiveness of single versus multiple screening moments for ROP detection and management.
Main Methods:
- Prospective recording of ROP incidence and course in premature infants over one year.
- Analysis of ROP detection rates based on single and multiple screening schedules.
Main Results:
- A single ROP screening likely detects less than 70% of all cases.
- The optimal timing for a single ROP screening, if necessary, is between the 7th and 9th weeks of life.
- Screening at the 4th-5th, 8th, and 11th weeks offers the best chance for accurate incidence approximation and optimal treatment timing.
Conclusions:
- The unpredictable nature of ROP progression complicates 100% detection with any screening schedule.
- Multiple ROP screenings are recommended for comprehensive monitoring and timely intervention.
- A strategy involving screenings in the 4th-5th, 8th, and 11th weeks is proposed for optimal ROP management.
Abstract:
Few data exist from which an optimal strategy for retinopathy of prematurity (ROP) screening can be deduced. This strategy should compromise between the dual purpose of screening, to wit monitoring the incidence of ROP and determining an optimal moment for therapeutic intervention. We recorded the timely incidence and course of ROP in all except four premature infants admitted during a 1-year period. The study results indicate that a single screening moment is not likely to detect more than 70% of all cases. When relying, however, on a single screening, the investigation should be performed between the 7th and 9th weeks. The unpredictable course of ROP, varying between early starting, rapidly progressing forms and very late starting, usually benign forms probably precludes the possibility of 100% ROP detection. Screening during the 4th to 5th, 8th, and 11th weeks probably gives the best chances for determination of an optimal moment for treatment and approximation of the incidence.